BioSpace News Archive

The global perfusion systems market expected to see steady growth in the coming years, as reported by Transparency Market Research.

Transparency Market Research has published a new report titled, “Endobronchial Ultrasound Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”.

A report published by Transparency Market Research sheds light on the key dynamics of the global market for bone densitometers and provides a basis to understand its competitive landscape.

Peptide synthesis refers to the process of creating short sequences of polypeptides through addition of one amino acid at a time.

The global canine arthritis treatment market is expected to weave a strong web of growth during the forecast period of 2019 to 2029.

Reduces engineering labor costs by 26%, enables evaluation of 60% more design alternatives and slashes physical testing and safety costs by 19%

Accuray Incorporated will report financial results for the fourth quarter and the 2020 fiscal year, ended June 30, 2020 after the market close on Thursday, August 13, 2020.

Detailed results from the positive Phase III THALES trial showed AstraZeneca’s BRILINTA® 90mg used twice daily and taken with daily aspirin for 30 days, reduced the rate of the primary composite endpoint of stroke and death by 17%, compared to aspirin alone in patients who had an acute ischemic stroke or transient ischemic attack.

Oncorus Announces Clinical Trial Collaboration with Merck to Evaluate the Combination of Oncorus’ ONCR-177 with Merck’s KEYTRUDA® (pembrolizumab) in Adult Patients with Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that it will report its financial results for the second quarter ended June 30, 2020, and provide an update on recent business highlights, on July 30, 2020. The Company will host a conference call and webcast on the same day at 8:30 a.m. ET to discuss the